
This target trial emulation using UK Biobank data evaluated statins and 5-year dementia risk in adults ≥55 years. Overall, sustained statin use did not reduce dementia risk. However, causal machine learning identified a subgroup with high non-APOE polygenic risk scores who demonstrated potential cognitive benefit, including reduced Alzheimer’s disease risk. Findings support genetically informed precision prevention strategies.
Like
Save
Share